1. Home
  2. LGIH vs CDNA Comparison

LGIH vs CDNA Comparison

Compare LGIH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$41.81

Market Cap

984.3M

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$17.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
CDNA
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
984.3M
1.0B
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
LGIH
CDNA
Price
$41.81
$17.30
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$75.90
$27.33
AVG Volume (30 Days)
393.6K
535.4K
Earning Date
05-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.12
N/A
Revenue
$1,705,504,000.00
$48,324,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.33
$11.23
P/E Ratio
$13.37
N/A
Revenue Growth
N/A
18.93
52 Week Low
$39.70
$10.96
52 Week High
$74.84
$21.49

Technical Indicators

Market Signals
Indicator
LGIH
CDNA
Relative Strength Index (RSI) 28.72 40.44
Support Level $41.82 $16.74
Resistance Level $55.90 $20.94
Average True Range (ATR) 1.88 0.80
MACD -1.00 -0.16
Stochastic Oscillator 16.85 34.48

Price Performance

Historical Comparison
LGIH
CDNA

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: